CORVO', RENZO GIACINTO
 Distribuzione geografica
Continente #
EU - Europa 36.336
AS - Asia 1.379
SA - Sud America 273
NA - Nord America 134
AF - Africa 24
OC - Oceania 1
Totale 38.147
Nazione #
IT - Italia 36.290
SG - Singapore 626
CN - Cina 400
VN - Vietnam 249
BR - Brasile 183
US - Stati Uniti d'America 86
AR - Argentina 50
HK - Hong Kong 37
MX - Messico 36
EC - Ecuador 15
ID - Indonesia 15
RU - Federazione Russa 12
BD - Bangladesh 10
ZA - Sudafrica 9
GB - Regno Unito 8
VE - Venezuela 8
CL - Cile 7
UA - Ucraina 7
IN - India 6
IQ - Iraq 5
PK - Pakistan 5
ES - Italia 4
MA - Marocco 4
PY - Paraguay 4
CO - Colombia 3
JO - Giordania 3
JP - Giappone 3
OM - Oman 3
BZ - Belize 2
CA - Canada 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
HU - Ungheria 2
KE - Kenya 2
KZ - Kazakistan 2
NL - Olanda 2
PL - Polonia 2
SA - Arabia Saudita 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BE - Belgio 1
BO - Bolivia 1
DE - Germania 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KW - Kuwait 1
LT - Lituania 1
LV - Lettonia 1
MY - Malesia 1
MZ - Mozambico 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PG - Papua Nuova Guinea 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
TG - Togo 1
TN - Tunisia 1
TR - Turchia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 38.147
Città #
Genova 21.738
Genoa 8.479
Rapallo 3.450
Vado Ligure 2.558
Singapore 368
Ho Chi Minh City 87
Beijing 83
Hanoi 51
Bordighera 50
Hong Kong 37
Ashburn 36
Mexico City 27
Tianjin 22
São Paulo 19
Haiphong 15
Biên Hòa 14
Da Nang 9
New York 9
Guangzhou 8
Hải Dương 8
Porto Alegre 8
Rio de Janeiro 7
Ninh Bình 6
Poplar 6
Caracas 5
Guayaquil 5
Quito 5
Buenos Aires 4
Bắc Giang 4
Can Tho 4
Johannesburg 4
Phoenix 4
Shijiazhuang 4
Thái Bình 4
Atlanta 3
Belo Horizonte 3
Bắc Ninh 3
Campinas 3
Catanduva 3
Caxias do Sul 3
Curitiba 3
Córdoba 3
Dallas 3
Kyiv 3
Los Angeles 3
Montes Claros 3
Moscow 3
São Bernardo do Campo 3
Thái Nguyên 3
Algiers 2
Amman 2
Asunción 2
Atibaia 2
Baixo Guandu 2
Bandung 2
Belém 2
Bogotá 2
Brasília 2
Bình Dương 2
Cairo 2
Camden 2
Campo Grande 2
Cape Town 2
Caruaru 2
Chennai 2
Chongqing 2
Denver 2
Dhaka 2
Jakarta 2
Karachi 2
Krasnodar 2
Machala 2
Mauá 2
Mendoza 2
Milan 2
Nanjing 2
Nha Trang 2
Phú Thọ 2
Piracicaba 2
Presidencia Roque Sáenz Peña 2
Quảng Ngãi 2
Ribeirão Preto 2
Rome 2
San Bernardo 2
San Jose 2
San Martín 2
Santa Maria 2
Santiago 2
Santo André 2
Secaucus 2
Seeb 2
Shanghai 2
Shenzhen 2
St Louis 2
São José do Rio Preto 2
Tatuí 2
Tokyo 2
Warsaw 2
Agadir 1
Aktobe 1
Totale 37.283
Nome #
Adjuvant intraoperative radiotherapy for selected breast cancers in previously irradiated women: Evidence for excellent feasibility and favorable outcomes 215
Image guided hypofractionated radiotherapy by helical tomotherapy for prostate carcinoma: toxicity and impact on Nadir PSA. 175
Comparison of local recurrence among early breast cancer patients treated with electron intraoperative radiotherapy vs hypofractionated photon radiotherapy an observational study 167
2.Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives. 167
Long-term survival in a patient with head and neck paraganglioma treated with tailored modalities for 20 years: A case report 166
Brachiterapia guidata dalle Immagini (MRI) nel carcinoma della cervice localmente avanzato: esperienza mono-istituzionale con 5 anni di follow-up 166
Complete response in a patient with gynecological hidradenocarcinoma treated with exclusive external beam radiotherapy and brachytherapy: a case report 165
Helical Tomotherapy targeting total bone marrow after total body irradiation for patients with relapsed acute leukemia undergoing an allogeneic stem cell transplant 162
Individualized treatment of head neck squamous cell carcinoma patients aged 70 or older with radiotherapy alone or associated to cisplatin or cetuximab: impact of weekly radiation dose on loco-regional control 162
A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects. 161
Advances in the implementation of helical tomotherapy-based total marrow irradiation with a novel field junction technique. 157
Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019 156
Low-dose fractionated total body irradiation (TBI) adversely affects prognosis of patients with leukemia receiving an HLA-matched allogeneic bone marrow transplant from an unrelated donor (UD-BMT). 150
Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy 147
Contralateral parotid-sparing radiotherapy in patients with unilateral squamous cell carcinoma of the head and neck : technical methodology and preliminary results. 146
The Susceptibility of Candida albicans to Gamma-Radiations and Ketoco-nazole Depends on Transitional Filamentation. 146
Simultaneous Integrated Boost in Once-weekly Hypofractionated Radiotherapy for Breast Cancer in the Elderly: Preliminary Evidence 146
Feasibility of helical tomotherapy for radical dose retreatment in pelvic area: a report of 4 cases. 143
Hamming clustering techniques for the identification of prognostic indices in patients with advanced head and neck cancer treated with radiation therapy. 143
Cell kinetics and tumor regression during radiotherapy in head and neck squamous-cell carcinomas. 142
Preoperative chemotherapy and radiotherapy in the management of epidermoid carcinoma of the anal canal. 141
Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019. 141
Hypofractionated irradiation of infra-supraclavicular lymph nodes after axillary dissection in patients with breast cancer post-conservative surgery: Impact on late toxicity 141
The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation. 140
Sequential vs alternate chemo-radiotherapy in advanced head and neck tumors. Report on a randomized study. 140
Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: An Italian multicenter observational study. 140
Management of oropharyngeal mycosis in head and neck cancer occurring during (chemo) radiotherapy: an Italian radio-oncologist survey 140
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 140
Applying radiation protection and safety in radiotherapy 140
The effects on pain and activity of daily living caused by crusted exudation in patients with head and neck cancer treated with cetuximab and radiotherapy. 139
Total body irradiation in acute myeloid leukemia and chronic myelogenous leukemia: influence of dose and dose-rate on leukemia relapse. 139
Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study. 139
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 138
Rete HTA- Regione Liguria - Criteri per l'appropriatezza allocativa di alcune apparecchiature - Volume 1 Acceleratori Lineari -LINAC 137
48: Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. 137
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 135
Accelerated partial breast irradiation via the mammosite catheter: preliminary reports of a single-institution experience. 134
New chemoradiotherapy combinations in head and neck cancer. 133
On the delineation of the gross tumor volume and clinical target volume for head and neck squamous cell carcinomas. 133
Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trials 133
Treatment with cisplatin and fluorouracil alternating with radiation favourably affects prognosis of inoperable squamous cell carcinoma of the head and neck: results of a multivariate analysis on 273 patients. 132
Biological and clinical implications for multimodality treatment in patients affected by squamous cell carcinoma of the head and neck. 132
Postoperative radiotherapy for head and neck squamous cell carcinomas: feasibility of a biphasic accelerated treatment schedule. 131
Integration of chemotherapy in an MFD--radiotherapy plan for advanced inoperable squamous cell carcinoma of the head and neck. 131
Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group. 130
A new in vitro model system to study antimycotic drugs. 130
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 130
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study. 129
Chemo-radiation association in head and neck squamous cell carcinoma: Evidences and criticisms 129
Cetuximab and Radiotherapy versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer : A Randomized Phase II trial 129
Intensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivity. 129
Alternating cisplatin-5-fluorouracil and radiotherapy in head and neck cancer. 128
Total body irradiation before allogeneic and autologous bone marrow transplantation: a ten year Genoa experience. 126
Neuroendocrine late effects after tailored photon radiotherapy for children with low grade gliomas: Long term correlation with tumour and treatment parameters 126
Tumor size-driven dose of intraoperative radiotherapy for breast cancer: 18 Gy versus 21 Gy 126
Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: a phase III study. 125
Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control. 125
Abdomino-pelvic radiotherapy (moving strip technique) after polichemotherapy with cisplatinum (CDDP) and second look laparatomy. Pilot study in advanced ovarian cancer. 124
Endothelial cells increase the radiosensitivity of oropharyngeal squamous carcinoma cells in collagen gel 124
Locally advanced non-metastatic breast cancer: analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approach. 123
Kinetic cell analysis by in vivo bromodeoxyuridine in squamous head and neck cancers: a tool for the radiotherapist. 123
Alternating gemcitabine and cisplatin with gemcitabine and radiation in stage IV squamous cell carcinoma of the head and neck. 123
In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen. 122
Chemotherapy alternated with radiotherapy in the treatment of advanced head and neck carcinoma: predictive factors of outcome. 122
Bone marrow transplantation (BMT) for acute nonlymphoid leukemia (ANLL) in first remission. 122
Reduction Mammaplasty and Intra-Operative Radiotherapy (IORT) in Conservative Surgery 122
Cardiotoxicity Assessment After Different Adjuvant Hypofractionated Radiotherapy Concurrently Associated with Trastuzumab in Early Breast Cancer 122
Preliminary experience using oncoplastic techniques of reduction mammaplasty and intraoperative radiotherapy: report of 2 cases. 122
Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome 121
Management of the neck after alternating chemoradiotherapy for advanced head and neck cancer 121
Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy [ARRIVE 1] 121
Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma. 120
Prevalence of Cardiovascular Disease and Osteoporosis During Androgen Deprivation Therapy Prescription Discordant to EAU Guidelines: Results From a Multicenter, Cross-sectional Analysis From the CHOsIng Treatment for Prostate canCEr (CHOICE) Study 120
Excellent survival regardless of disease stage in patients with advanced nasopharyngeal cancer 120
Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. 119
Radiation-induced emesis: a prospective observational multicenter italian trial 118
Multidisciplinary teams for the proper management of patients with genitourinary tumors: When topics set scientific societies' agenda 118
Structural and biomechanical properties of fixed bovine pericardium heart valve prostheses are not affected by ionizing radiation: an in-vitro study 118
New experience with breast volumetric modulation arc therapy (VMAT) realized with Trilogy Linac:comparison with Tomotherapy, Pros and Cons 117
Role of radiotherapy fractionation in head and neck cancers (MARCH): An updated meta-analysis 117
A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer: short term effects and radiotherapy: feasibility . 117
Cancer Stem Cells and response to ionizing radiations 116
Treatment of nasopharyngeal carcinoma: state of the art and new perspectives (review). 116
Longer intervals after neoadjuvant therapy in locally advanced rectal cancer: a monocentric experience 116
Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study 115
Circulating lymphocyte subsets after total lymphoid irradiation in chronicprogressive multiple sclerosis. 115
Management of Nasal Septum Chondrosarcoma Occurring in Elderly: A Case Report 115
Bio-radiation dermatitis: The need of a new grading: In regard to Bernier et al: Ann Oncol 2011; 22 (10): 2191-2200 115
The effect of total body irradiation dose and chronic graft-versus-host disease on leukaemic relapse after allogeneic bone marrow transplantation. 115
Tissue air ratio in total body irradiation. An in vivo evaluation. 114
Lack of a time-factor in alternating chemoradiotherapy for advanced head and neck squamous cell carcinoma. 114
Altered fractionation Radiotherapy or radiochemotherapy for patients with HNSCC: impact of meta-analysis results on clinical results. 114
IMRT with SIB in the treatment of anal cancer: a mono-institutional experience. 114
Retinoic acid modulates the radiosensitivity of head-and-neck squamous carcinoma cells grown in collagen gel. 113
What is the most effective treatment for head and neck squamous cell carcinoma?An individual patient data network meta-analysis from the MACH-NC and MARCH collaborative groups. 113
Total body irradiation correlates with chronic graft versus host disease and affects prognosis of patients with acute lymphoblastic leukemia receiving an HLA identical allogeneic bone marrow transplant. 112
Importance of set-up margins and set-up accuracy in Image Guided Total Marrow Irradiation 112
Image-guided radiation therapy (IGRT): practical recommendations of Italian Association of Radiation Oncology (AIRO) 112
The vicious Circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity 112
Co-culture with human fibroblasts increases the radiosensitivity of MCF-7 mammary carcinoma cells in collagen gels. 112
Totale 13.191
Categoria #
all - tutte 134.728
article - articoli 95.771
book - libri 900
conference - conferenze 25.717
curatela - curatele 2.232
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 10.108
Totale 269.456


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.433 0 0 0 0 0 244 111 210 255 246 170 197
2021/20224.698 115 392 141 616 255 405 288 1.060 226 421 131 648
2022/20234.207 489 120 81 353 764 832 15 316 752 12 409 64
2023/20241.866 99 327 47 198 163 306 99 81 117 33 104 292
2024/20255.889 83 601 186 327 927 617 470 752 260 367 544 755
2025/20264.471 1.126 239 595 965 1.275 271 0 0 0 0 0 0
Totale 38.637